Top Markets
#1 OriginTrail OriginTrail +33.25%
#2 Siren Siren +31.25%
#3 MarsCoin MarsCoin +13.99%
#4 Pons Pons +13.41%
#5 Waves Waves +10.06%
#6 Cysic Cysic +8.41%
#7 Tutorial Tutorial +8.05%
#8 Synapse Synapse +7.41%
#9 TROLL TROLL +6.94%
#10 Cortex Cortex +6.55%
Coin of the day
OriginTrail OriginTrail
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Chunghwa Chemical Synthesis & Biotech Co., Ltd. Chunghwa Chemical Synthesis & Biotech Co., Ltd.

Chunghwa Chemical Synthesis & Biotech Co., Ltd.

1762
Rang in Aktien #22434
Based in New Taipei City, Taiwan, Chunghwa Chemical Synthesis & Biotech Co.,... Based in New Taipei City, Taiwan, Chunghwa Chemical Synthesis & Biotech Co., Ltd., established in 1964 and previously known as China Chemical Synthesis Industry Co., Ltd., specializes in the development, production, and distribution of active pharmaceutical ingredients (APIs). The company's market reach includes Taiwan and the United States. Their API portfolio encompasses products designed for immunosuppression, oncology, and cardiovascular conditions, in addition to various peptide compounds. Moreover, they manufacture a wide array of bulk pharmaceutical substances for numerous therapeutic applications, including anti-anxiety agents, antidiabetics, laxatives, antifungals, antihistamines, antiseptics, antiulcerants, cardiovascular medications, skeletal muscle relaxants, hypolipidemics, antineoplastics, antihyperlipidemics, and immunosuppressants. Complementing its product offerings, Chunghwa Chemical Synthesis & Biotech delivers bespoke research and development as well as contract manufacturing services to both emerging drug developers and established generic pharmaceutical firms.
Aktienkurs
$1.15
Zuletzt synchronisiert: 2026-08-21
Marktkapitalisierung
$88.79M
Veränderung (1 Tag)
2.54%
Veränderung (1 Jahr)
27.30%
Land
TW
Handel Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762)

Kategorie

Healthcare
Aktien-Split-Historie für Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762)
Die Aktie Chunghwa Chemical Synthesis & Biotech Co., Ltd. (Symbol: 1762) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Aug 23, 2026 statt.
Eine 1762-Aktie, die vor dem Aug 23, 2026 gekauft wurde, entspricht heute 0 1762-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 0 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 0 -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 0 -
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 0 -
US
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 0 -
IT